Free Trial

Cytokinetics (CYTK) SEC Filings & 10K Form

Cytokinetics logo
$44.40 +1.09 (+2.52%)
Closing price 04:00 PM Eastern
Extended Trading
$44.41 +0.01 (+0.02%)
As of 06:24 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Cytokinetics SEC Filings

DateFilerForm TypeView
03/10/2025
6:30 AM
Cytokinetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/07/2025
7:39 PM
Blum Robert I (Reporting)
Cytokinetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2025
7:41 PM
Cytokinetics (Issuer)
Malik Fady Ibraham (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2025
7:43 PM
Callos Andrew (Reporting)
Cytokinetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2025
3:43 PM
Blum Robert I (Reporting)
Cytokinetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
4:06 PM
Cytokinetics (Subject)
Harrington Robert Arthur (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/27/2025
4:24 PM
Cytokinetics (Filer)
Form S-3ASR
02/12/2025
8:28 AM
Cytokinetics (Subject)
FMR LLC (Filed by)
Form SCHEDULE 13G/A
02/11/2025
7:26 AM
Cytokinetics (Issuer)
Landry Robert E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/11/2025
7:18 AM
Cytokinetics (Issuer)
Landry Robert E (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
02/11/2025
6:30 AM
Cytokinetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/04/2025
3:31 PM
Cytokinetics (Issuer)
Malik Fady Ibraham (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/10/2025
3:25 PM
Cytokinetics (Issuer)
Malik Fady Ibraham (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2025
10:29 AM
Cytokinetics (Subject)
VANGUARD GROUP INC (Filed by)
Form SCHEDULE 13G/A
01/07/2025
3:17 PM
Cytokinetics (Subject)
Malik Fady Ibraham (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/06/2025
3:22 PM
Cytokinetics (Issuer)
WIERENGA WENDALL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2025
3:23 PM
Cytokinetics (Issuer)
Wysenski Nancy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2025
3:25 PM
Cytokinetics (Issuer)
Kaye Edward M. MD (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2025
3:25 PM
Cytokinetics (Issuer)
Harrington Robert Arthur (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2025
3:27 PM
Cytokinetics (Issuer)
HENDERSON JOHN T (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/16/2024
6:23 PM
Cytokinetics (Issuer)
WIERENGA WENDALL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/16/2024
3:38 PM
Cytokinetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/16/2024
3:13 PM
Cytokinetics (Subject)
WIERENGA WENDALL (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/11/2024
9:17 AM
Cytokinetics (Subject)
HENDERSON JOHN T (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/10/2024
4:42 PM
Cytokinetics (Issuer)
Malik Fady Ibraham (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2024
3:30 PM
Cytokinetics (Issuer)
Lee Sung (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2024
3:32 PM
Cytokinetics (Issuer)
Wong Robert (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2024
3:22 PM
Callos Andrew (Reporting)
Cytokinetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2024
3:28 PM
Cytokinetics (Issuer)
Malik Fady Ibraham (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/02/2024
5:46 PM
Blum Robert I (Reporting)
Cytokinetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/02/2024
3:01 PM
Blum Robert I (Reporting)
Cytokinetics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/26/2024
6:05 PM
Cytokinetics (Issuer)
Malik Fady Ibraham (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/26/2024
4:38 PM
Cytokinetics (Issuer)
WIERENGA WENDALL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/25/2024
3:10 PM
Cytokinetics (Subject)
WIERENGA WENDALL (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/19/2024
5:02 AM
Cytokinetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/13/2024
4:04 PM
Cytokinetics (Issuer)
Malik Fady Ibraham (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/12/2024
8:55 AM
Cytokinetics (Subject)
FMR LLC (Filed by)
Form SC 13G/A
11/04/2024
4:45 PM
Blum Robert I (Reporting)
Cytokinetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/04/2024
10:17 AM
Cytokinetics (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
11/01/2024
3:43 PM
Blum Robert I (Reporting)
Cytokinetics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/31/2024
3:45 PM
Cytokinetics (Issuer)
Malik Fady Ibraham (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
Trump doesn’t give a damn (Ad)

Porter Stansberry: “I met with Trump’s biggest backers… they’re scooping up these 10 stocks” I recently met with one of Trump’s longest-serving advisors. We helped put together a plan to help investors capitalize on Trump’s election. And we found out these 10 stocks are the most likely to boom…

Go here now to find out the names of these 10 stocks.
10/31/2024
3:49 PM
Cytokinetics (Issuer)
WIERENGA WENDALL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/28/2024
3:12 PM
Cytokinetics (Subject)
WIERENGA WENDALL (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/23/2024
4:04 PM
BlackRock, Inc. (Filed by)
Cytokinetics (Subject)
Form SC 13G/A
10/16/2024
5:45 PM
Cytokinetics (Issuer)
Malik Fady Ibraham (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/15/2024
3:32 PM
Cytokinetics (Subject)
Malik Fady Ibraham (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/09/2024
3:08 PM
Blum Robert I (Reporting)
Cytokinetics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/03/2024
4:24 PM
Cytokinetics (Issuer)
Wysenski Nancy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2024
4:25 PM
Cytokinetics (Issuer)
WIERENGA WENDALL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2024
4:26 PM
Cytokinetics (Issuer)
Kaye Edward M. MD (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2024
4:27 PM
Cytokinetics (Issuer)
HENDERSON JOHN T (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2024
4:28 PM
Cytokinetics (Issuer)
Harrington Robert Arthur (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/01/2024
3:48 PM
Cytokinetics (Issuer)
Malik Fady Ibraham (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/30/2024
5:56 PM
Blum Robert I (Reporting)
Cytokinetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/17/2024
3:15 PM
Cytokinetics (Issuer)
Malik Fady Ibraham (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/16/2024
3:29 PM
Blum Robert I (Reporting)
Cytokinetics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/03/2024
4:06 PM
Cytokinetics (Issuer)
Pletcher Brett A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/03/2024
4:09 PM
Blum Robert I (Reporting)
Cytokinetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/03/2024
4:14 PM
Cytokinetics (Issuer)
Malik Fady Ibraham (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/22/2024
3:00 PM
Cytokinetics (Issuer)
Malik Fady Ibraham (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/19/2024
3:07 PM
Cytokinetics (Issuer)
Pletcher Brett A (Reporting)
Form 3/A
08/12/2024
4:31 PM
Cytokinetics (Issuer)
PARSHALL B LYNNE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/12/2024
4:32 PM
Blum Robert I (Reporting)
Cytokinetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/12/2024
3:21 PM
Blum Robert I (Reporting)
Cytokinetics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/07/2024
7:06 PM
Cytokinetics (Issuer)
Malik Fady Ibraham (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/06/2024
3:14 PM
Cytokinetics (Subject)
Malik Fady Ibraham (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/31/2024
3:36 PM
Blum Robert I (Reporting)
Cytokinetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/31/2024
3:39 PM
Cytokinetics (Issuer)
PARSHALL B LYNNE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/29/2024
3:17 PM
Cytokinetics (Subject)
PARSHALL B LYNNE (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/23/2024
3:47 PM
Cytokinetics (Issuer)
Malik Fady Ibraham (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/23/2024
3:21 PM
Cytokinetics (Subject)
Malik Fady Ibraham (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/16/2024
4:05 PM
Cytokinetics (Issuer)
PARSHALL B LYNNE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/15/2024
3:11 PM
Cytokinetics (Subject)
PARSHALL B LYNNE (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/10/2024
4:24 PM
Blum Robert I (Reporting)
Cytokinetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/09/2024
5:15 PM
Cytokinetics (Issuer)
Malik Fady Ibraham (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/09/2024
3:06 PM
Cytokinetics (Subject)
Malik Fady Ibraham (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/08/2024
4:06 PM
Cytokinetics (Issuer)
Harrington Robert Arthur (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/05/2024
3:03 PM
Cytokinetics (Subject)
Harrington Robert Arthur (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/03/2024
7:00 PM
Cytokinetics (Issuer)
Harrington Robert Arthur (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2024
7:02 PM
Cytokinetics (Issuer)
HENDERSON JOHN T (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2024
7:04 PM
Cytokinetics (Issuer)
Kaye Edward M. MD (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2024
7:05 PM
Cytokinetics (Issuer)
WIERENGA WENDALL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2024
7:07 PM
Cytokinetics (Issuer)
Wysenski Nancy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2024
4:12 PM
Cytokinetics (Issuer)
PARSHALL B LYNNE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2024
4:26 PM
Cytokinetics (Subject)
PARSHALL B LYNNE (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/01/2024
3:43 PM
Blum Robert I (Reporting)
Cytokinetics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/25/2024
7:04 PM
Cytokinetics (Issuer)
Malik Fady Ibraham (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2024
3:39 PM
Cytokinetics (Subject)
Malik Fady Ibraham (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/17/2024
4:13 PM
Blum Robert I (Reporting)
Cytokinetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2024
4:17 PM
Cytokinetics (Issuer)
PARSHALL B LYNNE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2024
4:22 PM
Blum Robert I (Reporting)
Cytokinetics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
A market crash is coming—here’s when (Ad)

The stock market cycle I've used to identify the most likely day of the next market crash is the exact same indicator that helped me call the bear market of 2018... the bull market in 2020... the bear market in 2022... the roaring bull markets in 2023 and 2024... and more. I'm convinced it has helped me identify the next big crash too. We are at an important juncture in the markets. Knowing what to do in the months to come is critical.

Click here to check out my full write-up.
06/17/2024
3:24 PM
Cytokinetics (Subject)
PARSHALL B LYNNE (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/11/2024
4:16 PM
Cytokinetics (Subject)
Malik Fady Ibraham (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/10/2024
4:08 PM
Bhanji Muna (Reporting)
Cytokinetics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/07/2024
4:13 PM
Cytokinetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/05/2024
4:23 PM
Cytokinetics (Issuer)
Harrington Robert Arthur (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2024
9:02 AM
Cytokinetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/04/2024
3:30 PM
Cytokinetics (Issuer)
PARSHALL B LYNNE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2024
3:36 PM
Cytokinetics (Subject)
PARSHALL B LYNNE (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/03/2024
3:33 PM
Cytokinetics (Issuer)
Wong Robert (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)

Remove Ads

Related Companies and Tools


This page (NASDAQ:CYTK) was last updated on 3/11/2025 by MarketBeat.com Staff
From Our Partners